Anti-MAPT Neutralizing Antibody (V3S-0723-FY233) (CAT#: V3S-0723-FY233)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description cDC8E8 is a recombinant human antibody that identifies human MAPT. It also reacts with mouse. The chimeric antibody cDC8E8 exhibits an KD of 0.37 nM. Tau is a member of a family of intrinsically disordered proteins known for lacking a rigid three-dimensional structure in their natural environment. Tau truncation is a significant posttranslational modification associated with the neurofibrillary degeneration observed in Alzheimer's disease.
Clonality Monoclonal
Host Species Human
Target Species Human, Mouse
Affinity 0.37 nM
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application Block; IHC

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target MAPT
Alternative Name TAU; MSTD; PPND; DDPAC; MAPTL; MTBT1; MTBT2; FTDP-17; PPP1R103
Gene ID 4137
UniProt P10636
Research Area Neuroscience; Signal Pathway
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry